Search: L773:1751 7176 OR L773:1524 6175
> (2020-2024) >
Resistance to antih...
Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study
-
- Wijkman, Magnus (author)
- Linköpings universitet,Medicinska fakulteten,Avdelningen för diagnostik och specialistmedicin,Region Östergötland, Medicinkliniken ViN,Harvard Med Sch, MA 02115 USA
-
- Malachias, Marcus V. B. (author)
- Fundacao Educ Lucas Machado, Brazil
-
- Claggett, Brian L. (author)
- Harvard Med Sch, MA 02115 USA
-
show more...
-
- Cheng, Susan (author)
- Cedars Sinai Med Ctr, CA 90048 USA
-
- Matsushita, Kunihiro (author)
- Johns Hopkins Univ, MD USA
-
- Shah, Amil M. (author)
- Harvard Med Sch, MA 02115 USA
-
- Jhund, Pardeep S. (author)
- Univ Glasgow, Scotland
-
- Coresh, Josef (author)
- Johns Hopkins Univ, MD USA
-
- Solomon, Scott D. (author)
- Harvard Med Sch, MA 02115 USA
-
- Vardeny, Orly (author)
- Minneapolis VA Hlth Care Syst, MN USA; Univ Minnesota, MN USA
-
show less...
-
(creator_code:org_t)
- 2021-09-21
- 2021
- English.
-
In: The Journal of Clinical Hypertension. - : Wiley. - 1524-6175 .- 1751-7176. ; 23:10, s. 1887-1896
- Related links:
-
https://liu.diva-por... (primary) (Raw object)
-
show more...
-
https://onlinelibrar...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- More stringent blood pressure (BP) goals have led to greater prevalence of apparent resistant hypertension (ARH), yet the long-term prognostic impact of ARH diagnosed according to these goals in the general population remains unknown. We assessed the prognostic impact of ARH according to contemporary BP goals in 9612 participants of the Atherosclerosis Risk in Communities (ARIC) study without previous cardiovascular disease. ARH, defined as BP above goal (traditional goal <140/90 mmHg, more stringent goal <130/80 mmHg) despite the use of >= 3 antihypertensive drug classes or any BP with >= 4 antihypertensive drug classes (one of which was required to be a diuretic) was compared with controlled hypertension (BP at goal with 1-3 antihypertensive drug classes). Cox regression models were adjusted for age, sex, race, study center, BMI, heart rate, smoking, eGFR, LDL, HDL, triglycerides, and diabetes. Using the traditional BP goal, 133 participants (3.8% of the treated) had ARH. If the more stringent BP goal was instead applied, 785 participants (22.6% of the treated) were reclassified from controlled hypertension to uncontrolled hypertension (n = 725) or to ARH (n = 60). Over a median follow-up time of 19 years, ARH was associated with increased risk for a composite end point (all-cause mortality, hospitalization for myocardial infarction, stroke, or heart failure) regardless of whether traditional (adjusted HR 1.50, 95% CI: 1.23-1.82) or more stringent (adjusted HR 1.43, 95% CI: 1.20-1.70) blood pressure goals were applied. We conclude that in patients free from cardiovascular disease, ARH predicted long-term risk regardless of whether traditional or more stringent BP criteria were applied.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Allmänmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- General Practice (hsv//eng)
Keyword
- antihypertensive therapy; epidemiology; resistant hypertension
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Wijkman, Magnus
-
Malachias, Marcu ...
-
Claggett, Brian ...
-
Cheng, Susan
-
Matsushita, Kuni ...
-
Shah, Amil M.
-
show more...
-
Jhund, Pardeep S ...
-
Coresh, Josef
-
Solomon, Scott D ...
-
Vardeny, Orly
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and General Practice
- Articles in the publication
-
The Journal of C ...
- By the university
-
Linköping University